ClariVest Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,151
| Closed | -$310K | – | 894 |
|
|
2023
Q4 | $310K | Buy |
10,151
+2,770
| +38% | +$84.5K | 0.02% | 376 |
|
|
2023
Q3 | $233K | Hold |
7,381
| – | – | 0.01% | 368 |
|
|
2023
Q2 | $301K | Sell |
7,381
-500
| -6% | -$20.4K | 0.02% | 363 |
|
|
2023
Q1 | $294K | Buy |
7,881
+22
| +0.3% | +$821 | 0.01% | 412 |
|
|
2022
Q4 | $274K | Sell |
7,859
-13
| -0.2% | -$453 | 0.01% | 417 |
|
|
2022
Q3 | $441K | Sell |
7,872
-22
| -0.3% | -$1.23K | 0.02% | 375 |
|
|
2022
Q2 | $408K | Hold |
7,894
| – | – | 0.02% | 404 |
|
|
2022
Q1 | $574K | Sell |
7,894
-4
| -0.1% | -$291 | 0.02% | 364 |
|
|
2021
Q4 | $933K | Sell |
7,898
-514
| -6% | -$60.7K | 0.03% | 333 |
|
|
2021
Q3 | $1.13M | Buy |
8,412
+4,718
| +128% | +$633K | 0.04% | 303 |
|
|
2021
Q2 | $598K | Buy |
+3,694
| New | +$598K | 0.02% | 403 |
|
|
2017
Q2 | – | Sell |
-6,412
| Closed | -$90K | – | 704 |
|
|
2017
Q1 | $90K | Sell |
6,412
-2,665
| -29% | -$37.4K | ﹤0.01% | 565 |
|
|
2016
Q4 | $119K | Sell |
9,077
-267
| -3% | -$3.5K | ﹤0.01% | 522 |
|
|
2016
Q3 | $159K | Buy |
+9,344
| New | +$159K | ﹤0.01% | 521 |
|